Skin Testing and ELISPOT Assay in Patients With a History of Non-Immediate Reactions to Cephalosporins

NCT01248377 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2011-10-12

No results posted yet for this study

Summary

This study aims to compare the results of skin testing and ELISPOT assay in patients with a history of non-immediate reactions to cephalosporins

Conditions

  • Cephalosporin Allergy
  • Non-immediate Drug Reactions

Interventions

PROCEDURE

Skin tests and ELISPOT assay

Patch test and/or intradermal test will be performed in patients as well as cytokine secretions from PBMCs will be analyzed by ELISPOT assay

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Jettanong Klaewsongkram, MD · Chulalongkorn University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01248377 on ClinicalTrials.gov